Requirement for capsule in colonization by Streptococcus pneumoniae

被引:182
作者
Magee, AD [1 ]
Yother, J [1 ]
机构
[1] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
关键词
D O I
10.1128/IAI.69.6.3755-3761.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nasopharyngeal colonization is a necessary first step in the pathogenesis of Streptococcus pneumoniae. Using isolates containing defined mutations in the S. pneumoniae capsule locus, we found that expression of the capsular polysaccharide is essential for colonization by the type 2 strain D39 and the type 3 strains A66 and WU2. Nonencapsulated derivatives of each of these strains were unable to colonize BALB/cByJ mice. Similarly, type 3 mutants that produced <6% of the parental amounts of capsule could not colonize. Capsule production equivalent to that of the parent strain was not required for efficient colonization, however, as type 3 mutants producing approximately 20% of the parental amounts of capsule colonized as effectively as the parent. This 80% reduction in capsule level had only a minimal effect on intraperitoneal virulence but caused a significant reduction in virulence via the intravenous route. In the X-linked immunodeficient CBA/N mouse, the type 3 mutant producing similar to 20% of the parental amount of capsule (AM188) was diminished in its ability to cause invasive disease and death following intranasal inoculation. Following intravenous or intraperitoneal challenge, however, only extended survival times were observed. Our results demonstrate an additional role for capsule in the pathogenesis of S. pneumoniae and show that isolates producing reduced levels of capsule can remain highly virulent.
引用
收藏
页码:3755 / 3761
页数:7
相关论文
共 58 条
[1]   Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS-2B) [J].
Adamou, JE ;
Wizemann, TM ;
Barren, P ;
Langermann, S .
INFECTION AND IMMUNITY, 1998, 66 (02) :820-822
[2]   SOME ASPECTS OF THE PNEUMOCOCCAL CARRIER STATE [J].
AUSTRIAN, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :35-45
[3]   STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III [J].
Avery, Oswald T. ;
MacLeod, Colin M. ;
McCarty, Maclyn .
JOURNAL OF EXPERIMENTAL MEDICINE, 1944, 79 (02) :137-158
[4]  
AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73
[5]   Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae [J].
Berry, AM ;
Paton, JC .
INFECTION AND IMMUNITY, 1996, 64 (12) :5255-5262
[6]  
BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
[7]   The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection [J].
Briles, DE ;
Hollingshead, S ;
Brooks-Walter, A ;
Nabors, GS ;
Ferguson, L ;
Schilling, M ;
Gravenstein, S ;
Braun, P ;
King, J ;
Swift, A .
VACCINE, 2000, 18 (16) :1707-1711
[8]   Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae [J].
Briles, DE ;
Ades, E ;
Paton, JC ;
Sampson, JS ;
Carlone, GM ;
Huebner, RC ;
Virolainen, A ;
Swiatlo, E ;
Hollingshead, SK .
INFECTION AND IMMUNITY, 2000, 68 (02) :796-800
[9]   ANTI-PHOSPHOCHOLINE ANTIBODIES FOUND IN NORMAL MOUSE SERUM ARE PROTECTIVE AGAINST INTRAVENOUS INFECTION WITH TYPE-3 STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
NAHM, M ;
SCHROER, K ;
DAVIE, J ;
BAKER, P ;
KEARNEY, J ;
BARLETTA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :694-705
[10]  
BRILES DE, 1986, CURR TOP MICROBIOL, V124, P103